Sign Up to like & get
recommendations!
0
Published in 2020 at "American Heart Journal"
DOI: 10.1016/j.ahj.2020.05.010
Abstract: Abstract Background There is much debate on the use of angiotensin receptor blockers (ARBs) in SARS-CoV-2 infected patients. While it has been suggested that ARBs might lead to a higher susceptibility and severity of SARS-CoV-2…
read more here.
Keywords:
trial;
valsartan;
covid trial;
praetorian covid ... See more keywords